Inhibition of PFKFB3 in HER2-Positive Gastric Cancer Improves Sensitivity to Trastuzumab by Inducing Tumor Vessel Normalisation

The authors established trastuzumab-resistant cells and patient-derived xenografts models to measure metabolic levels and vascular density and shape.